Drawing for RHINALLERGY

USPTO serial 79202658

RHINALLERGY

Reviewed by CopyMark Law Group

Reg. 5388822Status 404
Filing date
Status date
Registration date
Jan 30, 2018
Examiner
BAKER, JORDAN A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RHINALLERGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JANET G RICCIUTI

JANET G RICCIUTI JANET GILBERT RICCIUTI, PC1830 S STREET, NWWASHINGTON, DC 20009UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Homeopathic pharmaceutical products for the treatment of allergic conjunctivitis and rhinitisSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 26, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 30, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 14, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 8, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 2, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 2, 2018FIMPFINAL DISPOSITION PROCESSED—
Apr 30, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 30, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 25, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 2, 2017ALIEASSIGNED TO LIE—
Sep 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 15, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2017RFNTREFUSAL PROCESSED BY IB—
Apr 4, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 4, 2017RFRRREFUSAL PROCESSED BY MPU—
Apr 2, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2017DOCKASSIGNED TO EXAMINER—
Mar 7, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 3, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 2, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance